Abstract
Schizophrenia is a common disorder with a life time prevalence of approximately 1 per cent1. The illness often develops in young adults, who were previously normal, and is characterized by a constellation of symptoms including hallucinations and delusions (psychotic symptoms) and symptoms such as severely inappropriate emotional responses, a disorder of thinking and concentration, erratic behaviour as well as social and occupational deterioration2. A considerable proportion of the variance in the liability to develop schizophrenia may be genetic3,4, but segregation analysis, to establish a mode of transmission, has not produced a consistent result5–19. One of these studies was carried out in Iceland and made use of the large family size and extensive geneaological information present in that country16,17. Here we demonstrate genetic linkage of two DNA polymorphisms on the long arm of human chromosome 5 to schizophrenia in seven British and Icelandic families with multiple affected members. The results indicate the existence of a gene locus with a dominant schizophrenia-susceptibility allele. Inheritance of the allele in the families studied suggests that it may also predispose to psychiatric conditions such as schizophrenia spectrum disorders and a variety of other disorders. This report provides the first strong evidence for the involvement of a single gene in the causation of schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gottesman, I. I. Schizophrenia: The Epigenetic Puzzle (Cambridge University Press, New York 1982).
Beuler, M. The Schizophrenia Disorders (Yale, New Haven 1978).
Fulker, D. W. Social Biol. 20, 266–275 (1973).
McGue, M., Gottesman, I. I. & Rao, D. C. Genet. Epidemiol. 46, 44–55 (1985).
O'Rourke, D. H., Gottesman, I. I., Suarez, B. K., Rice, J. & Reich, T. Am. J. hum. Genet. 34, 630–649 (1983).
Risch, N. & Baron, M. Am. J. hum. Genet. 36, 1039–1059 (1984).
Carter, C. L. & Chung, C. S. Hum. Hered. 30, 350–356 (1974).
Elston, R. C., Kringlen, E. & Namboodiri, K. K. Behav. Genet. 3, 101–106 (1973).
Kidd, K. K. & Cavalli-Sforza, L. L. Social Biol. 20, 254–265 (1973).
Rao, D. C., Morton, N. E., Gottesman, I. I. & Low, R. Hum. Hered. 31, 325–333 (1981).
Tsuang, M. T., Bucher, K. D. & Fleming, J. A. Br. J. Psychiat. 140, 595–599 (1982).
Baron, M. Am. J. Psychiat. 133, 1070–1073 (1976).
Slater, E. Acta. genet. Statist. Med. 8, 50–56 (1958).
Debray, Q., Cailard, V. & Stewart, J. Neuropsychobiology 134, 687–688 (1978).
Rudin, E. Zur Verebung und Neuentstehung der Dementia praecox (Springer, Berlin, 1916).
Karlsson, J. Br. J. Psychiat. 140, 600–606 (1982).
Karlsson, J. Br. J. Psychiat. 152, 324–329 (1988).
Book, J. A., Wetterberg, L. & Modrzewska, K. Clin. Genet. 14, 373–394 (1978).
Leonhard, K. Br. J. Psychiat. 149, 1–6 (1986).
Elston, R. C., Namboodiri, K. K., Spence, M. A. & Rainer, J. D. Neurophysiobiology 4, 193–206 (1978).
Turner, W. J. Biol. Psychiat. 14, 177–206 (1979).
McGuffin, P., Festenstein, H. & Murray, R. Psychol. Med. 13, 31–43 (1983).
Andrew, B., Watt, D. C., Gillespie, C. & Chapel, H. Psychol. Med. 17, 363–370 (1987).
Gurling, H. M. D. et al. A Genetic Perspective for Schizophrenia and Related Disorder (eds Smeraldi, E. & Bellodi, L.) 43–48 (Edi-Hermes, Milan, 1988).
Clin. Genet. 20, 363–402 (1981).
Bassett, A. S. et al. Lancet i, 799–780 (1988).
Smith, R., Ardinger, H. A., DeHaven, C. R., Murray, J. C. & Buetow, K. H. Cytogenet. Cell Genet. 46, 694 (1988).
Gurling, H. M. D. et al. Schizophrenia Research 1 (in the press).
Detera-Wadleigh, S. et al. American college neuropsychopharmacology meeting (1987).
Spitzer, R. L., Endicott, J. & Robins, E. Research Diagnostic Criteria for a Selected Group of Functional Disorders 3rd edn (New York State Psychiatric Institute, New York, 1978).
Diagnostic and Statistical Manual for Mental Disorders edn 3. (American Psychiatric Association, Committee on Nomenclature and Statistics, Washington DC, 1980).
Leppert, M. et al. Science 238, 1411–1413 (1988).
Leppert, M. et al. Cytogenet. Cell Genet. 46, 649 (1987).
Piazza, A., Menozzi, P., Cavalli-sforza, L. L. Proc. natn. Acad. Sci. 78, 2638–2642 (1981).
Gurling, H. M. D. Psychiat. Dev. 4, 287–309 (1986).
Gurling, H. M. D. Psychiat. Dev. 3, 257–273 (1985).
Ott, J. Analysis of Human Genetic Linkage (Johns Hopkins University Press, Baltimore, 1985).
Ott, J. Am. J. hum. Genet. 39, 159–165 (1986).
Risch, N. Am. J. hum. Genet. 42, 353–364 (1988).
Hodgkinson, S. et al. Nature 325, 805–806 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sherrington, R., Brynjolfsson, J., Petursson, H. et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336, 164–167 (1988). https://doi.org/10.1038/336164a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/336164a0
This article is cited by
-
Transcriptome analysis of fibroblasts from schizophrenia patients reveals differential expression of schizophrenia-related genes
Scientific Reports (2020)
-
Genetic insights into the neurodevelopmental origins of schizophrenia
Nature Reviews Neuroscience (2017)
-
A joint history of the nature of genetic variation and the nature of schizophrenia
Molecular Psychiatry (2015)
-
Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain
Translational Psychiatry (2015)
-
Puzzling over schizophrenia: Schizophrenia as a pathway disease
Nature Medicine (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
